openPR Logo
Press release

Vertebroplasty and Kyphoplasty Market Company Analysis and Forecast to 2025

08-07-2017 04:19 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Vertebroplasty and Kyphoplasty Market Company Analysis

Vertebral fracture is one of the major medical conditions in economies in the West. Pain and deformity, impacting the quality of life, are major problems that entail this type of fracture. Medical therapy is the cornerstone of vertebral body fracture management, excluding neurological impairment, including bed rest, rehabilitation, orthoses, and analgesics. Effectiveness of such treatment modalities is observed in a majority of patients. Kyphoplasty and vertebroplasty are two percutaneous minimally invasive methods for vertebral augmentation, developed to manage symptomatic fractures without neurological impairment, for application of cement into vertebral body. Kyphoplasty was introduced to help realign the spine and manage kyphotic deformity. It includes placing an inflatable balloon device (bone tamp) percutaneously into vertebral body. The U.S. FDA approved this procedure in 1998. The inflation of bone with liquid enables correction of kyphosis and restoration of vertebral height. The cavity produced after inflation is filled by an injection of polymethylmethacrylate (PMMA).

Read the Comprehensive Overview of Vertebroplasty and Kyphoplasty Market: http://www.transparencymarketresearch.com/vertebroplasty-kyphoplasty-market.html

In order to manage an aggressive, painful hemangioma of vertebral body, vertebroplasty (a minimally invasive percutaneous method) was introduced with an aim to inject PMMA cement percutaneously into the collapsed vertebral body to strengthen it, under imaging guidance. Kyphoplasty and vertebroplasty have been widely accepted across the globe. These methods help in managing patients without neurological impairment, who suffer from otherwise unmanageable pain resulting from vertebral compression fractures due to osteolytic lesions and osteoporosis within the vertebral body. These procedures depend on fracture’s mechanical stabilization, produced by injecting PMMA cement into fractured vertebra.

Limitations in traditional techniques for treating vertebral compression fractures drive the global vertebroplasty and kyphoplaty devices market. These advanced procedures result in stabilization, pain relief of the fracture, avoiding downward spiral of untreated osteoporosis. Soaring geriatric population has resulted into a rise in the number of patients with osteoporosis. Kyphoplasty and vertebroplasty require shorter surgical time, providing discharge to patients in less than a day. These procedures require general anesthesia and enable the patients to return soon to their daily routine. No bracing is needed for these procedures. These factors are expected to fuel market growth in the near future. In contrast, chances of another fracture occurrence and complications such as post-surgery infection and bleeding are expected to retrain the global vertebroplasty & kyphoplasty devices market.

The vertebroplasty & kyphoplasty devices market has been categorized based on surgery, product, end-user, and region. In terms of surgery, the market has been segmented into vertebroplasty and kyphoplasty. Based on product type, the market has been categorized into devices, needles, cement mixing & delivery devices, X-ray equipment, and balloons. The devices segment has been sub-segmented into vertebroplasty and kyphoplasty devices. In terms of end-user, the vertebroplasty and kyphoplasty market has been segmented into hospitals, diagnostic centers, research institutes, and others. Increasing prevalence of vertebral compression fractures (VCF) owing to increasing geriatric population is fueling demand for vertebroplasty and kyphoplasty devices.

In terms of region, the vertebroplasty and kyphoplasty devices market has been segmented into Asia Pacific, Europe, Middle East & Africa, North America, and Latin America. Increasing number of surgical procedures has made North America the most lucrative market for vertebroplasty and kyphoplasty devices. In addition, high economic contribution of healthcare, availability of well-established health care infrastructure, and patient compliance drive demand for vertebroplasty and kyphoplasty devices in the region. Europe is another lucrative market for vertebroplasty and kyphoplasty devices due to technological advancements in the health care sector in the region. Asia Pacific is projected to register higher growth rate than North America and Europe driven by growing opportunities in emerging economies such as India and China.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=23156

Key players in the global vertebroplasty and kyphoplasty devices market include DePuy Synthes, CareFusion Corporation, Alphatec Spine, Inc., G-21 s.r.l., Medtronic, Inc., Stryker Corporation, Osseon LLC., Taeyeon Medical Co., Ltd., BMK Global Medical Company, Globus Medical, Inc., and SOMATEX.

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vertebroplasty and Kyphoplasty Market Company Analysis and Forecast to 2025 here

News-ID: 658102 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Kyphoplasty

Market Analysis and Insights : Asia-Pacific Kyphoplasty Market
Asia-Pacific Kyphoplasty Market - Industry Trends and Forecast to 2028 Asia-Pacific kyphoplasty market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 15.2% in the above mentioned forecast period. The major players covered in the Asia-Pacific kyphoplasty market report are Medtronic, Johnson & Johnson Services, Inc, iMEDICOM, Joline GmbH and Co. KG, TAEYEON MEDICAL,
Vertebroplasty and Kyphoplasty Devices Market 2022 | Detailed Report
The study provides an in-depth analysis of the major market players in the Vertebroplasty and Kyphoplasty Devices market. It provides a detailed analysis of each segment and driving factors coupled with growth rate analysis. Furthermore, the report also provides regional analysis that offers insights on the market potential across each region to enable market players to leverage market opportunities. The Vertebroplasty and Kyphoplasty Devices research report provides region-wise and country-wise
Kyphoplasty Systems Market Expected to Deliver Dynamic Progression until 2028(Ba …
Vertebral compression fracture is one of the most common osteoporotic fractures, which leads to kyphotic deformities, depression, weight loss, reduced quality of life, persistent pain and even death. Osteoporosis is a major cause of vertebral compression fracture in elderly women. Multiple myeloma, metastatic bone disease, traumatic injuries and metastatic spinal tumors can also lead to vertebral compression fractures. According to the International Journal of Surgery-Elsevier, VCF occurs in 16% of
Vertebroplasty and Kyphoplasty Devices Market Report 2018: Segmentation by Type …
Global Vertebroplasty and Kyphoplasty Devices market research report provides company profile for Kinetic Medical, Benvenue, Spine Wave, Teknimed, Medtronic, Stryker, J&J (Depuy Synthes), Globus Medical, Merit Medical and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to
South America Kyphoplasty Devices Market Analysis and Forecast 2023
"The Report MediPoint: Kyphoplasty Devices - South America Analysis and Market Forecasts provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Kyphoplasty Device Market Vertebral compression fractures (VCFs) are often characterized by pain and deformity due to the fracture and collapse of one or more vertebral bodies in the spinal column. Primarily caused by osteoporosis and osteopenia, conditions characterized by loss of bone
Europe Analysis OF Kyphoplasty Devices Market Forecast 2023
"The Report MediPoint: Kyphoplasty Devices - Europe Analysis and Market Forecasts provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Kyphoplasty Devices Market Vertebral compression fractures (VCFs) are often characterized by pain and deformity due to the fracture and collapse of one or more vertebral bodies in the spinal column. Primarily caused by osteoporosis and osteopenia, conditions characterized by loss of bone